首页 | 本学科首页   官方微博 | 高级检索  
     


Positron emission tomography in esophageal cancer
Authors:Hiroyuki Kato  Minoru Fukuchi  Tatsuya Miyazaki  Masanobu Nakajima  Hitoshi Kimura  Ahmad Faried  Makoto Sohda  Yasuyuki Fukai  Norihiro Masuda  Ryokuhei Manda  Hitoshi Ojima  Katsuhiko Tsukada  Noboru Oriuchi  Keigo Endo  Hiroyuki Kuwano
Affiliation:(1) Department of General Surgical Science (Surgery I), Gunma University, Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi 371-8511, Japan;(2) Department of Diagnostic Radiology and Nuclear Medicine, Gunma University, Maebashi, Japan
Abstract:Positron emission tomography (PET), a functional imaging modality, has provided the transition between the research environment and the clinical environment over the last 10 years. Its primary use is in the field of oncology, where it is being increasingly used in the management of several tumor types including esophageal cancer. 18F-Fluorodeoxyglucose PET (FDG-PET) scans may also be used to distinguish between benign and malignant tumors, to identify different stages of tumor spread, to assess for tumor recurrence, and monitor the response to therapy of malignant diseases. This review aims to outline the current and future roles of PET scanning in the field of esophageal cancer.
Keywords:Esophageal cancer  18F-Fluorodeoxyglucose (FDG)  Positron emission tomography (PET)  Staging  Response to therapy
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号